Maxime Turgeon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maxime Turgeon has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Aurélie Labbe
Department of Decision Sciences, HEC Montréal, Montréal, QC H3T 2A7, Canada
2 shared publications - Celia Margaret T. Greenwood
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada
2 shared publications For The Alzheimer’s Disease Neuroimaging Initiative
2 shared publicationsGolsa Dehghan
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada
2 shared publications- Karim Oualkacha
Département de mathématiques, Université du Québec à Montréal, Montréal, Canada
2 shared publications - Pedro Rosa-Neto
Montreal Neurological Institute, McGill University Health Centre, Montréal, Québec, Canada
2 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Springer Nature in AStA Advances in Statistical Analysis
- p. 1-27
A Bayesian factor analysis model for high-dimensional microbiome count data
Dimension reduction techniques are among the most essential analytical tools in the analysis of high-dimensional data. Generalized principal component analysis (PCA) is an extension to standard PCA that has been widely used to identify low-dimensional features in high-dimensional discrete data, such as binary, multi-category and count data. For microbiome count data in particular, the multinomial PCA is a natural counterpart of the standard PCA. However, this technique fails to account for the excessive number of zero values, which is frequently observed in microbiome count data. To allow for sparsity, zero-inflated multivariate distributions can be used. We propose a zero-inflated probabilistic PCA model for latent factor analysis. The proposed model is a fully Bayesian factor analysis technique that is appropriate for microbiome count data analysis. In addition, we use the mean-field-type variational family to approximate the marginal likelihood and develop a classification variational approximation algorithm to fit the model. We demonstrate the efficiency of our procedure for predictions based on the latent factors and the model parameters through simulation experiments, showcasing its superiority over competing methods. This efficiency is further illustrated with two real microbiome count datasets. The method is implemented in .
- 12 October 2026
- Published by Springer Nature in AStA Advances in Statistical Analysis
- p. 1-27
Open AccessA Bayesian factor analysis model for high-dimensional microbiome count data
Dimension reduction techniques are among the most essential analytical tools in the analysis of high-dimensional data. Generalized principal component analysis (PCA) is an extension to standard PCA that has been widely used to identify low-dimensional features in high-dimensional discrete data, such as binary, multi-category and count data. For microbiome count data in particular, the multinomial PCA is a natural counterpart of the standard PCA. However, this technique fails to account for the excessive number of zero values, which is frequently observed in microbiome count data. To allow for sparsity, zero-inflated multivariate distributions can be used. We propose a zero-inflated probabilistic PCA model for latent factor analysis. The proposed model is a fully Bayesian factor analysis technique that is appropriate for microbiome count data analysis. In addition, we use the mean-field-type variational family to approximate the marginal likelihood and develop a classification variational approximation algorithm to fit the model. We demonstrate the efficiency of our procedure for predictions based on the latent factors and the model parameters through simulation experiments, showcasing its superiority over competing methods. This efficiency is further illustrated with two real microbiome count datasets. The method is implemented in .
- 14 October 2017
- Published by The R Foundation
covequal: Test for Equality of Covariance Matrices
- 5 December 2016
- Published by The R Foundation
pcev: Principal Component of Explained Variance
- 26 July 2016
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 27 (5) , 1331-1350
Principal component of explained variance: An efficient and optimal data dimension reduction framework for association studies
The genomics era has led to an increase in the dimensionality of data collected in the investigation of biological questions. In this context, dimension-reduction techniques can be used to summarise high-dimensional signals into low-dimensional ones, to further test for association with one or more covariates of interest. This paper revisits one such approach, previously known as principal component of heritability and renamed here as principal component of explained variance (PCEV). As its name suggests, the PCEV seeks a linear combination of outcomes in an optimal manner, by maximising the proportion of variance explained by one or several covariates of interest. By construction, this method optimises power; however, due to its computational complexity, it has unfortunately received little attention in the past. Here, we propose a general analytical PCEV framework that builds on the assets of the original method, i.e. conceptually simple and free of tuning parameters. Moreover, our framework extends the range of applications of the original procedure by providing a computationally simple strategy for high-dimensional outcomes, along with exact and asymptotic testing procedures that drastically reduce its computational cost. We investigate the merits of the PCEV using an extensive set of simulations. Furthermore, the use of the PCEV approach is illustrated using three examples taken from the fields of epigenetics and brain imaging.
- 26 July 2016
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 27 (5) , 1331-1350
Principal component of explained variance: An efficient and optimal data dimension reduction framework for association studies
The genomics era has led to an increase in the dimensionality of data collected in the investigation of biological questions. In this context, dimension-reduction techniques can be used to summarise high-dimensional signals into low-dimensional ones, to further test for association with one or more covariates of interest. This paper revisits one such approach, previously known as principal component of heritability and renamed here as principal component of explained variance (PCEV). As its name suggests, the PCEV seeks a linear combination of outcomes in an optimal manner, by maximising the proportion of variance explained by one or several covariates of interest. By construction, this method optimises power; however, due to its computational complexity, it has unfortunately received little attention in the past. Here, we propose a general analytical PCEV framework that builds on the assets of the original method, i.e. conceptually simple and free of tuning parameters. Moreover, our framework extends the range of applications of the original procedure by providing a computationally simple strategy for high-dimensional outcomes, along with exact and asymptotic testing procedures that drastically reduce its computational cost. We investigate the merits of the PCEV using an extensive set of simulations. Furthermore, the use of the PCEV approach is illustrated using three examples taken from the fields of epigenetics and brain imaging.
- Open Access
Principal component of explained variance: an efficient and optimal data dimension reduction framework for association studies
The genomics era has led to an increase in the dimensionality of the data collected to investigate biological questions. In this context, dimension-reduction techniques can be used to summarize high-dimensional signals into low-dimensional ones, to further test for association with one or more covariates of interest. This paper revisits one such approach, previously known as Principal Component of Heritability and renamed here as Principal Component of Explained Variance (PCEV). As its name suggests, the PCEV seeks a linear combination of outcomes in an optimal manner, by maximising the proportion of variance explained by one or several covariates of interest. By construction, this method optimises power but limited by its computational complexity, it has unfortunately received little attention in the past. Here, we propose a general analytical PCEV framework that builds on the assets of the original method, i.e. conceptually simple and free of tuning parameters. Moreover, our framework extends the range of applications of the original procedure by providing a computationally simple strategy for high-dimensional outcomes, along with exact and asymptotic testing procedures that drastically reduce its computational cost. We investigate the merits of the PCEV using an extensive set of simulations. Furthermore, the use of the PCEV approach will be illustrated using three examples taken from the epigenetics and brain imaging areas.
Open AccessPrincipal component of explained variance: an efficient and optimal data dimension reduction framework for association studies
The genomics era has led to an increase in the dimensionality of the data collected to investigate biological questions. In this context, dimension-reduction techniques can be used to summarize high-dimensional signals into low-dimensional ones, to further test for association with one or more covariates of interest. This paper revisits one such approach, previously known as Principal Component of Heritability and renamed here as Principal Component of Explained Variance (PCEV). As its name suggests, the PCEV seeks a linear combination of outcomes in an optimal manner, by maximising the proportion of variance explained by one or several covariates of interest. By construction, this method optimises power but limited by its computational complexity, it has unfortunately received little attention in the past. Here, we propose a general analytical PCEV framework that builds on the assets of the original method, i.e. conceptually simple and free of tuning parameters. Moreover, our framework extends the range of applications of the original procedure by providing a computationally simple strategy for high-dimensional outcomes, along with exact and asymptotic testing procedures that drastically reduce its computational cost. We investigate the merits of the PCEV using an extensive set of simulations. Furthermore, the use of the PCEV approach will be illustrated using three examples taken from the epigenetics and brain imaging areas.
- Open Access
- 28 May 2015
- Published by Springer Nature in Nature Communications
- Vol. 6 (1) , 7060
A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease
In observational studies, type-2 diabetes (T2D) is associated with an increased risk of coronary heart disease (CHD), yet interventional trials have shown no clear effect of glucose-lowering on CHD. Confounding may have therefore influenced these observational estimates. Here we use Mendelian randomization to obtain unconfounded estimates of the influence of T2D and fasting glucose (FG) on CHD risk. Using multiple genetic variants associated with T2D and FG, we find that risk of T2D increases CHD risk (odds ratio (OR)=1.11 (1.05–1.17), per unit increase in odds of T2D, P=8.8 × 10−5; using data from 34,840/114,981 T2D cases/controls and 63,746/130,681 CHD cases/controls). FG in non-diabetic individuals tends to increase CHD risk (OR=1.15 (1.00–1.32), per mmol·per l, P=0.05; 133,010 non-diabetic individuals and 63,746/130,681 CHD cases/controls). These findings provide evidence supporting a causal relationship between T2D and CHD and suggest that long-term trials may be required to discern the effects of T2D therapies on CHD risk.
- 28 May 2015
- Published by Springer Nature in Nature Communications
- Vol. 6 (1) , 7060
Open AccessA Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease
In observational studies, type-2 diabetes (T2D) is associated with an increased risk of coronary heart disease (CHD), yet interventional trials have shown no clear effect of glucose-lowering on CHD. Confounding may have therefore influenced these observational estimates. Here we use Mendelian randomization to obtain unconfounded estimates of the influence of T2D and fasting glucose (FG) on CHD risk. Using multiple genetic variants associated with T2D and FG, we find that risk of T2D increases CHD risk (odds ratio (OR)=1.11 (1.05–1.17), per unit increase in odds of T2D, P=8.8 × 10−5; using data from 34,840/114,981 T2D cases/controls and 63,746/130,681 CHD cases/controls). FG in non-diabetic individuals tends to increase CHD risk (OR=1.15 (1.00–1.32), per mmol·per l, P=0.05; 133,010 non-diabetic individuals and 63,746/130,681 CHD cases/controls). These findings provide evidence supporting a causal relationship between T2D and CHD and suggest that long-term trials may be required to discern the effects of T2D therapies on CHD risk.
The perils of quasi‐likelihood information criteria
In this paper, we consider some potential pitfalls of the growing use of quasi‐likelihood‐based information criteria for longitudinal data to select a working correlation structure in a generalized estimating equation framework. In particular, we examine settings where the fully conditional mean does not equal the marginal mean as well as hypothesis testing following selection of the working correlation matrix. Our results suggest that the use of any information criterion for selection of the working correlation matrix is inappropriate when the conditional mean model assumption is violated. We also find that type I error differs from the nominal level in moderate sample sizes following selection of the form of the working correlation but improves as sample size is increased as the selection is then concentrated on a single correlation structure. Our results serve to underline the potential dangers that can arise when using information criteria to select correlation structure in routine data analysis. Copyright © 2015 John Wiley & Sons, Ltd.
The perils of quasi‐likelihood information criteria
In this paper, we consider some potential pitfalls of the growing use of quasi‐likelihood‐based information criteria for longitudinal data to select a working correlation structure in a generalized estimating equation framework. In particular, we examine settings where the fully conditional mean does not equal the marginal mean as well as hypothesis testing following selection of the working correlation matrix. Our results suggest that the use of any information criterion for selection of the working correlation matrix is inappropriate when the conditional mean model assumption is violated. We also find that type I error differs from the nominal level in moderate sample sizes following selection of the form of the working correlation but improves as sample size is increased as the selection is then concentrated on a single correlation structure. Our results serve to underline the potential dangers that can arise when using information criteria to select correlation structure in routine data analysis. Copyright © 2015 John Wiley & Sons, Ltd.